spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  COGNIS 

 HSMN NewsFeed - 18 Jun 2024
Roche receives FDA clearance on its digital pathology solution for diagnostic use
Devices Diagnostics FDA
 HSMN NewsFeed - 27 May 2024
Roche And Hitachi High-Tech Extend their 46-Year Partnership, Paving the Way for Further Breakthroughs in Diagnostic Testing
Diagnostics
 HSMN NewsFeed - 20 Dec 2023
FeelTect secures €1.5 million investment for connected wound treatment technology
Devices Wound Care Monitoring Venture Capital
 HSMN NewsFeed - 2 Feb 2023
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Oct 2022
DePuy Synthes Receives FDA Clearance for TELIGEN(TM) System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 25 Mar 2022
Roche announces collaboration with Bristol Myers Squibb to advance personalised healthcare through digital pathology solutions
Diagnostics
 HSMN NewsFeed - 10 Jan 2022
Breakthrough in Device Therapy for Patients with Late-Stage Heart Disease
Devices Cardiology
 HSMN NewsFeed - 7 Jan 2022
NICE recommends first smartphone-based ECG for the detection of atrial fibrillation (AF) for people with suspected paroxysmal AF in an ambulatory monitoring setting
Devices Monitoring Cardiology
 HSMN NewsFeed - 15 Dec 2021
Roche Launches the First Infectious Disease Tests and Cobas Omni Utility Channel for Use on the Cobas 5800 System in Countries Accepting the CE Mark
Diagnostics Product Launch
 HSMN NewsFeed - 9 Mar 2021
Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer patients eligible for targeted treatment with LORBRENA (lorlatinib)
Diagnostics Oncology FDA
 HSMN NewsFeed - 10 Nov 2020
Tezepelumab NAVIGATOR Phase 3 Trial Met Primary Endpoint Of A Statistically Significant And Clinically Meaningful Reduction In Exacerbations In A Broad Population Of Patients With Severe Asthma
Biopharmaceuticals
 HSMN NewsFeed - 29 Oct 2020
Roche receives FDA approval for the cobas EGFR Mutation Test v2 as the first companion diagnostic test for expanded EGFR TKI therapies in patients with non-small cell lung cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 5 Jun 2020
Sosei Heptares Notes Phase IIIb ARGON Study With Enerzair(R) Breezhaler(R) (QVM149) Meets Primary Endpoint in Patients With Uncontrolled Asthma
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 17 Mar 2020
Roche begins shipments of first 400,000 COVID-19 tests to laboratories across US to begin patient testing under FDA Emergency Use Authorization
Diagnostics Product Launch
 HSMN NewsFeed - 19 Nov 2019
New study shows 96% healing of hard to treat large and massive rotator cuff tears with Smith & Nephew's REGENETEN(TM) Bioinductive Implant
Devices Orthopaedic
 HSMN NewsFeed - 13 Sep 2019
Largest Ever Hip Fracture Fixation Trial in Over 1,000 Patients Demonstrates Unprecedently Low Cut-Out Rates for X-BOLT(R) Device
Devices Orthopaedic
 HSMN NewsFeed - 20 May 2019
Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss
Regenerative Medicine Venture Capital Personnel
 HSMN NewsFeed - 21 Dec 2018
BTG Announces National Reimbursement for TheraSphere(R) in France
Devices Oncology Reimbursement
 HSMN NewsFeed - 20 Nov 2018
FDA Approves Gamifant(R) (emapalumab), the First and Only Treatment for Primary Haemophagocytic Lymphohistiocytosis (HLH)
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Nov 2018
Sobi(TM) to Acquire Synagis(R) US Rights From AstraZeneca - Creates a Platform for Global Growth
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 23 Oct 2018
COMPASS Pathways Receives FDA Breakthrough Therapy Designation for Psilocybin Therapy for Treatment-resistant Depression
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Aug 2018
Sobi(TM) Appoints Anne Marie de Jonge Schuermans as Head of Technical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2018
Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
Devices Monitoring Product Launch
 HSMN NewsFeed - 14 May 2018
FDA approves additional claim for Roche cobas Zika test
Diagnostics FDA
 HSMN NewsFeed - 16 Apr 2018
Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
Diagnostics FDA
 HSMN NewsFeed - 13 Oct 2017
Esaote Introduces the MyLab(TM) 9 Ultrasound Platform
Devices Product Launch
 HSMN NewsFeed - 26 Jul 2017
Roche Launches the Avenio Millisect System for Precise and Efficient Dissection of Tissue Biopsies
Diagnostics Product Launch
 HSMN NewsFeed - 17 Jul 2017
CHMP Issues a Positive Opinion for Daiichi Sankyo's Once-Daily LIXIANA(R) (edoxaban) in Patients with Atrial Fibrillation Undergoing Cardioversion
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 1 Jun 2017
Roche announces FDA approval of companion diagnostic to identify ALK-positive non-small cell lung cancer patients
Diagnostics Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Apr 2017
Roche Launches Antibody Test to Aid in Diagnosis of Challenging Prostate Cancer Cases
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 19 Jan 2017
Ethypharm Acquires Martindale Pharma in the UK
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 28 Nov 2016
Conditional Approval from the European Commission to Treat Multiple Myeloma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 Nov 2016
AbbVie's HUMIRA(R) (Adalimumab) Receives CHMP Positive Opinion to Treat Adolescents with Hidradenitis Suppurativa, a Chronic Inflammatory Skin Disease
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 3 Oct 2016
Launch of Carrick Therapeutics Signals New Approach to Cancer Therapies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 5 Sep 2016
Eisai Bewildered as German Institute for Quality and Efficiency in Health Care (IQWIG) Fails to Recognise Additional Benefit of Halaven(R) (eribulin) in the Treatment of Advanced Liposarcoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 Aug 2016
Roche receives FDA Emergency Use Authorization for Zika PCR Test
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Jul 2016
US FDA pathway opens to SCENESSE(R) following Fast Track designation for treatment of EPP
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Jul 2016
Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 30 Jun 2016
Martindale Pharma(R) Announces Extension of Licensing Agreement With Unimedic AB to Include Emergency Care Product Portfolio
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 May 2016
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
Diagnostics FDA
 HSMN NewsFeed - 9 May 2016
Signostics Launches Uscan(TM) in Europe - the World's First Smart Mobile-connected Visualisation Device Specialised for Urologic Care
Devices Urology Product Launch
 HSMN NewsFeed - 19 Nov 2015
Oncimmune Appoints Dr James Jett, World Recognised Lung Cancer Specialist, as Chief Medical Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 26 Oct 2015
CareFusion Signs Exclusive Distribution Agreement With AAM Healthcare For Video Laryngoscope
Devices Distribution
 HSMN NewsFeed - 24 Sep 2015
EU Marketing Approval Granted for VivaGel(R) BV
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Sep 2015
AbbVie's HUMIRA(R) (Adalimumab) Receives First and Only U.S. Food and Drug Administration Approval for Moderate to Severe Hidradenitis Suppurativa
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 2 Sep 2015
ADC Therapeutics Secures $80m Financing to Progress Its Pipeline of Antibody Drug Conjugate Therapeutics in Oncology
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 Aug 2015
NICE Recommends Once-daily Lixiana(R) (Edoxaban) for Preventing Stroke and Systemic Embolism in People with Non-valvular Atrial Fibrillation
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 16 Jul 2015
Immunocore Secures $320 Million (£205 Million) in Europe's Largest Private Life Sciences Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 1 Jul 2015
GlySure Secures CE Mark and Launches World’s First Continuous Intravascular Glucose Monitoring System
Devices Monitoring Regulatory
 HSMN NewsFeed - 27 May 2015
Boston Scientific Names Prof. John Mark Morgan as Senior Medical Director, Rhythm Management
Devices Cardiology Personnel
 HSMN NewsFeed - 16 Dec 2014
Crescendo Biologics' Receives Further Investment from Astellas Venture Management to Develop Novel Humabody(TM) Therapeutics Targeting Immune Checkpoint Inhibitors
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 22 Apr 2014
Cellnovo Strengthens Senior Management Team with Three Key Hires
Devices Endocrinology Personnel
 HSMN NewsFeed - 4 Feb 2014
BOTOX(R) (Botulinum toxin type A) Receives Approval in the UK for the Treatment of Ankle Disability due to Lower Limb Spasticity Associated with Stroke in Adults
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 23 Dec 2013
Blue Belt Technologies announces first Navio(TM) Unicondylar Knee Replacement performed in France
Devices Orthopaedic
 HSMN NewsFeed - 17 Dec 2013
Crescendo Biologics Raises £17.5M ($28M) in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 22 Nov 2013
Tivicay(R) (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV
Biopharmaceuticals HIV/AIDS Regulatory
 HSMN NewsFeed - 9 Sep 2013
Keystone Heart's TriGuard(TM) Cerebral Protection Device Receives CE Marking
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 24 Jun 2013
Aircraft Medical puts Competitors on Notice of 70 Patents and Design Rights in Key Video Laryngoscope Markets
Devices
 HSMN NewsFeed - 24 May 2013
PBAC Approves XIFAXAN(R) (Rifaxamin α) 550 mg Cost Effectiveness in Australia
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Apr 2013
Vascular Flow Appoints Jonathan Sackier to Board
Devices Personnel
 HSMN NewsFeed - 12 Mar 2013
TiGenix to Obtain National Reimbursement in Spain for Its Innovative Cartilage Therapy ChondroCelect(R)
Regenerative Medicine Orthopaedic Reimbursement
 HSMN NewsFeed - 18 Jan 2013
ThromboGenics Receives Positive CHMP Opinion for JETREA(R)
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 7 Dec 2012
Dr. Reddy's Launches Debiopharm's Pamorelin(R) LA in India for the Treatment of Locally Advanced or Metastatic, Hormone-Dependent Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Nov 2012
Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 26 Oct 2012
NICE Approves Pharmaxis' Bronchitol(R) As An Important New Treatment Option For Cystic Fibrosis Patients
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Aug 2012
Genetic Technologies Receives CE Mark Approval for BREVAGen(TM)
Diagnostics Personalized Medicine Oncology Regulatory
 HSMN NewsFeed - 8 Jun 2012
Aircraft Medical Launches the McGRATH(R) MAC 2 Blade for Paediatric Patients
Devices
 HSMN NewsFeed - 31 May 2012
Boston Scientific Increases Longevity Projections for Its U.S. Defibrillators
Devices Cardiology
 HSMN NewsFeed - 25 May 2012
Advanced Biological Laboratories' DeepChek(R) and ViroScore(R) Suite Clinical Genotyping Solutions For Personalized Treatment of HIV Receive CE Mark for In Vitro Diagnostic Use
Diagnostics HIV/AIDS Regulatory
 HSMN NewsFeed - 23 Dec 2011
Allergan Reassures Patients and Surgeons of the Quality and Safety of Its Breast Implant Devices Sold and Distributed Worldwide
Devices
 HSMN NewsFeed - 23 Aug 2011
Spinifex Closes AU$18.25M(~US$19M) Expanded Series B Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Jul 2011
New Cancer Treatment Device Goes Into Service Today
Devices Neurosurgery Oncology
 HSMN NewsFeed - 6 May 2011
Boston Scientific Begins International Launch and First Implants of Next-Generation Devices to Treat Heart Failure and Sudden Cardiac Death
Devices Cardiology
 HSMN NewsFeed - 5 May 2011
Boston Scientific Offers New CRT-D Warranty Program Covering Phrenic Nerve Stimulation
Devices Cardiology
 HSMN NewsFeed - 4 May 2011
NxStage(R) Advances Global Growth Strategy with System One Regulatory Approval and Distribution Agreement in Australia and New Zealand
Devices Distribution
 HSMN NewsFeed - 10 Jan 2011
Orexo: FDA Approval For Abstral (Fentanyl) Sublingual Tablets - US Launch Planned For Q1 2011
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Sep 2010
Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds
Devices Cardiology
 HSMN NewsFeed - 12 Jul 2010
Mirada Medical Announces the Appointment of Karsten Damgaard-Iversen as Non-Executive Chairman
Devices Radiology Personnel
 HSMN NewsFeed - 8 Jul 2010
Boston Scientific Announces First Patient Enrollment in MultiSENSE Clinical Trial
Devices Cardiology
 HSMN NewsFeed - 3 Jun 2010
Elan Corporation, plc Board Announces CEO Agreement
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2010
STELARA(TM) Significantly Improves Symptoms of Depression, Anxiety and Health-Related Quality of Life in Patients With Moderate to Severe Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 27 Apr 2010
CRESTOR(TM) Gains New EU Indication to Prevent Major Cardiovascular Events in High Risk Patients
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 10 Feb 2010
Boston Scientific Rebuts HeartRhythm Article
Devices Cardiology
 HSMN NewsFeed - 18 Jan 2010
Carl Zeiss Meditec Continues Successful Growth Strategy with New Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 24 Nov 2009
Oxagen Limited Raises £16 Million in Series C Private Venture Capital Financing Led by Novartis Venture Funds
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 16 Nov 2009
GSK and Nabi Announce Agreement for NicVAX(R), a Vaccine for Nicotine Addiction
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Nov 2009
Boston Scientific's Most Advanced Devices to Treat Heart Failure and Sudden Cardiac Death Now Available in Japan
Devices Cardiology Regulatory
 HSMN NewsFeed - 13 Oct 2009
Amarin Announces Changes to Its Board and Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jul 2009
Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Jul 2009
Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System
Devices Cardiology Regulatory
 HSMN NewsFeed - 1 Jul 2009
Eisai and Pfizer Decide not to Appeal NICE Decision and Call for an Expedited Review of Guidance for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 May 2009
Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process
Devices Cardiology Regulatory
 HSMN NewsFeed - 11 May 2009
Debiopharm and Mepha Sign Distribution Agreement for Pamorelin(R) LA
Biopharmaceuticals Oncology Distribution
 HSMN NewsFeed - 10 Dec 2008
ICON Medical Imaging Launches New Cardiac Echocardiography Analysis Software
Devices Cardiology
 HSMN NewsFeed - 25 Nov 2008
Renishaw acquires a 75% interest in Schaerer Mayfield NeuroMate AG and gains a solid foothold in the robot assisted neurosurgery market
Devices Neurosurgery
 HSMN NewsFeed - 24 Oct 2008
Boston Scientific Announces Canadian Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Devices Cardiology Regulatory
 HSMN NewsFeed - 19 May 2008
Launch of Highly Targeted Cancer Treatment Tasigna(R) (nilotinib) Offers Potential Lifeline to Ph+ CML Patients Intolerant or Resistant to Existing Therapies, Including Glivec(R) (imatinib)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2008
Boston Scientific Announces FDA Approval of New Heart Failure Lead
Devices Cardiology FDA
 HSMN NewsFeed - 13 May 2008
Boston Scientific Announces FDA Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Devices Cardiology FDA
 HSMN NewsFeed - 7 May 2008
Astellas' Mycamine(R) (micafungin) Licensed for Use in Europe to Treat Serious Fungal Infections
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Feb 2008
Boston Scientific Announces First European Implants of New Devices to Treat Heart Failure and Sudden Cardiac Death
Devices Cardiology
 HSMN NewsFeed - 12 Feb 2008
Sosei Announces Start of AD 923 Phase III Studies in Europe
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 22 Jan 2008
Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
Devices Cardiology Regulatory
 HSMN NewsFeed - 5 Dec 2007
New Data Reinforces the Superiority of Escitalopram Over Duloxetine for Acute Treatment of Depression
Biopharmaceuticals
 HSMN NewsFeed - 6 Nov 2007
AAIPharma Expands Central and Eastern European Operations
Biopharmaceuticals
 HSMN NewsFeed - 27 Sep 2007
First European IGRT School Takes Place for Radiotherapy Practitioners in UK
Devices Oncology
 HSMN NewsFeed - 21 Sep 2007
SORIN GROUP: Andre-Michel Ballester Appointed Chief Executive Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 6 Jun 2007
Innocoll Announces Filing of Investigational New Drug Application for its CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 1 Jun 2007
Genomic Health Announces Exclusive Distribution Agreement for Oncotype DX Breast Cancer Assay in United Kingdom
Diagnostics Distribution Oncology
 HSMN NewsFeed - 10 May 2007
Meda Acquire Rights to the First Combination of an NSAID (Ketoprofen) and a Proton Pump Inhibitor (Omeprazole)
Biopharmaceuticals
 HSMN NewsFeed - 27 Apr 2007
Meda Acquires Product Portfolio from the US Pharma Company Wyeth
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 1 Feb 2007
AstraZeneca Acquires Arrow Therapeutics To Broaden Anti-Infective Capabilities
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Jan 2007
Agreement between Ipsen and MSD for the Co-Marketing in France of Adrovance(TM) for the Treatment of Postmenopausal Osteoporosis
Biopharmaceuticals Licensing
 HSMN NewsFeed - 18 Jan 2007
Cipralex Approved in Europe for the Treatment of Obsessive Compulsive Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Dec 2006
Cambridge Antibody Technology Announces Senior Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Oct 2006
ELAPRASE(TM) (idursulfase) Receives Positive Opinion in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Sep 2006
Final data from Antisoma's AS1404 lung cancer trial show clear survival benefit
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Sep 2006
Xenical(R) Shown to Improve Control of Blood Glucose Levels in People With Type 2 Diabetes Beyond Impact of Weight Loss Alone
Biopharmaceuticals
 HSMN NewsFeed - 31 May 2006
Varian Medical Systems Equipment Selected for Wave 9 of UK Cancer Plan
Devices Oncology
 HSMN NewsFeed - 17 May 2006
Pieris Appoints New Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 May 2006
Acambis announces forthcoming retirement of Chief Scientific Officer
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 39

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 39 additional stories matching:
COGNIS
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.